Please ensure Javascript is enabled for purposes of website accessibility

Argenta Is Delighted to Meet You at the 15th International Congress of the European Association of Veterinary Pharmacology and Toxicology (EAVPT)

Argenta Is Delighted to Meet You at the 15th International Congress of the European Association of Veterinary Pharmacology and Toxicology (EAVPT)

Argenta is pleased to extend a warm invitation to the 15th International Congress of the European Association of Veterinary Pharmacology and Toxicology (EAVPT), where we will be present as an official sponsor. The congress will take place in the captivating city of Bruges, Belgium, from Sunday 2 July 2023 to Wednesday 5 July 2023.

The EAVPT congress provides a platform for professionals in the field to exchange knowledge, share experiences, and discuss significant topics that shape veterinary research and development. We will have an active participation in the congress, engaging in presentations and poster sessions to shed light on critical subjects impacting the industry.

Dr. Klaus Hellmann, Chief Veterinary Officer at Argenta and a distinguished speaker at the event, will talk about "Experiences with test permits and GMP requirement for veterinary clinical studies." Dr. Hellmann's presentation will delve into the challenges and insights gained from navigating the regulatory landscape surrounding test permits and Good Manufacturing Practice (GMP) requirements for veterinary clinical studies. This topic helps to ensure the safety and efficacy of veterinary medications through rigorous testing and compliance with regulatory standards.

Argenta's presence at the congress will also be highlighted through the presentation of three informative posters, each focusing on key aspects of regulatory compliance and research in the veterinary field. The first poster, titled "Regulation (EU) 2021-805 amending Annex II to Regulation (EU) 2019/6: challenges for R&D," will explore the implications and challenges arising from the recent amendment to the European Union (EU) regulation. This amendment directly affects the research and development processes within the veterinary industry and highlights the importance of adapting to evolving regulatory frameworks.

The second poster, "Methane production and performance in dairy cows fed with RumenProof CF*," explores the relationship between diet and methane production in dairy cows. This research contributes to the broader understanding of sustainable livestock practices by investigating the impact of specific feed additives on methane emissions and the overall performance of dairy cattle.

The third poster, titled "Limited Market applications in the EU: experiences under Regulation EU 2019/6," examine the complexities associated with limited market applications within the EU. This research sheds light on the challenges faced by pharmaceutical companies seeking to bring veterinary products to market, offering insights into the regulatory framework and potential strategies for overcoming barriers to entry.

The 15th International Congress of EAVPT serves as a valuable platform for the exchange of ideas and experiences, fostering collaboration among veterinary professionals and pharmaceutical stakeholders. We invite you to join Argenta's sessions, which address key topics such as regulatory compliance, research and development challenges, and sustainable livestock practices. We are committed to advancing the field of veterinary pharmacology and toxicology in partnership with our customers, ultimately benefiting animal health and welfare.

Should you require any assistance with your projects, we are happy to welcome you at Argenta’s booth. Our experts Dr. Klaus Hellmann and Dr. Claudia Schneider, Head of Clinical Studies Unit, Auditor (EOQ), KLIFOVET GmbH, will be available to provide guidance and support.

Please feel free to reach out to us to learn more about how Argenta can assist you in your endeavours.

Continue Reading